Cargando…

Cyclin-Dependent Kinase Synthetic Lethality Partners in DNA Damage Response

Cyclin-dependent kinases (CDKs) are pivotal mediators and effectors of the DNA damage response (DDR) that regulate both the pathway components and proteins involved in repair processes. Synthetic lethality (SL) describes a situation in which two genes are linked in such a way that the lack of functi...

Descripción completa

Detalles Bibliográficos
Autores principales: Kciuk, Mateusz, Gielecińska, Adrianna, Mujwar, Somdutt, Mojzych, Mariusz, Kontek, Renata
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8998982/
https://www.ncbi.nlm.nih.gov/pubmed/35408915
http://dx.doi.org/10.3390/ijms23073555
_version_ 1784685076379860992
author Kciuk, Mateusz
Gielecińska, Adrianna
Mujwar, Somdutt
Mojzych, Mariusz
Kontek, Renata
author_facet Kciuk, Mateusz
Gielecińska, Adrianna
Mujwar, Somdutt
Mojzych, Mariusz
Kontek, Renata
author_sort Kciuk, Mateusz
collection PubMed
description Cyclin-dependent kinases (CDKs) are pivotal mediators and effectors of the DNA damage response (DDR) that regulate both the pathway components and proteins involved in repair processes. Synthetic lethality (SL) describes a situation in which two genes are linked in such a way that the lack of functioning of just one maintains cell viability, while depletion of both triggers cell death. Synthetic lethal interactions involving CDKs are now emerging, and this can be used to selectively target tumor cells with DNA repair defects. In this review, SL interactions of CDKs with protooncogene products MYC, poly (ADP-ribose) polymerase (PARP-1), and cellular tumor antigen p53 (TP53) are discussed. The individual roles of each of the SL partners in DDR are described.
format Online
Article
Text
id pubmed-8998982
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-89989822022-04-12 Cyclin-Dependent Kinase Synthetic Lethality Partners in DNA Damage Response Kciuk, Mateusz Gielecińska, Adrianna Mujwar, Somdutt Mojzych, Mariusz Kontek, Renata Int J Mol Sci Review Cyclin-dependent kinases (CDKs) are pivotal mediators and effectors of the DNA damage response (DDR) that regulate both the pathway components and proteins involved in repair processes. Synthetic lethality (SL) describes a situation in which two genes are linked in such a way that the lack of functioning of just one maintains cell viability, while depletion of both triggers cell death. Synthetic lethal interactions involving CDKs are now emerging, and this can be used to selectively target tumor cells with DNA repair defects. In this review, SL interactions of CDKs with protooncogene products MYC, poly (ADP-ribose) polymerase (PARP-1), and cellular tumor antigen p53 (TP53) are discussed. The individual roles of each of the SL partners in DDR are described. MDPI 2022-03-24 /pmc/articles/PMC8998982/ /pubmed/35408915 http://dx.doi.org/10.3390/ijms23073555 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Kciuk, Mateusz
Gielecińska, Adrianna
Mujwar, Somdutt
Mojzych, Mariusz
Kontek, Renata
Cyclin-Dependent Kinase Synthetic Lethality Partners in DNA Damage Response
title Cyclin-Dependent Kinase Synthetic Lethality Partners in DNA Damage Response
title_full Cyclin-Dependent Kinase Synthetic Lethality Partners in DNA Damage Response
title_fullStr Cyclin-Dependent Kinase Synthetic Lethality Partners in DNA Damage Response
title_full_unstemmed Cyclin-Dependent Kinase Synthetic Lethality Partners in DNA Damage Response
title_short Cyclin-Dependent Kinase Synthetic Lethality Partners in DNA Damage Response
title_sort cyclin-dependent kinase synthetic lethality partners in dna damage response
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8998982/
https://www.ncbi.nlm.nih.gov/pubmed/35408915
http://dx.doi.org/10.3390/ijms23073555
work_keys_str_mv AT kciukmateusz cyclindependentkinasesyntheticlethalitypartnersindnadamageresponse
AT gielecinskaadrianna cyclindependentkinasesyntheticlethalitypartnersindnadamageresponse
AT mujwarsomdutt cyclindependentkinasesyntheticlethalitypartnersindnadamageresponse
AT mojzychmariusz cyclindependentkinasesyntheticlethalitypartnersindnadamageresponse
AT kontekrenata cyclindependentkinasesyntheticlethalitypartnersindnadamageresponse